Jorge Fortun, MD
Ophthalmology · Palm Beach Gardens, FLNPI 1184736464
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $504,210 of the $797,682 with a category attached, or 63.2%. It is spread thinly across 29 manufacturers, the largest accounting for just 18.9%. Among ophthalmology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 679 payments — averaging $1174.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$151K
- Novartis$127K
- Astellas Pharma US Inc$104K
- Alimera Sciences, Inc.$97K
- Regeneron Healthcare Solutions, Inc.$76K
- Dutch Ophthalmic, USA$57K
- plus $187K from 23 others
Across 20 payments — averaging $7395.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$80K
- Alimera Sciences, Inc.$36K
- Novartis$32K
What the payments were for
- Consulting fees$216,92627%
- Speaking & faculty fees$504,21063%
- Travel & lodging$49,7236%
- Food & beverage$24,7163%
- Education$1,0500%
- Entertainment$1,0560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 119 | $150,676 |
| Novartis | 87 | $126,513 |
| Astellas Pharma US Inc | 74 | $103,877 |
| Alimera Sciences, Inc. | 56 | $96,575 |
| Regeneron Healthcare Solutions, Inc. | 82 | $76,379 |
| Dutch Ophthalmic, USA | 40 | $56,885 |
| ANI Pharmaceuticals, Inc. | 24 | $41,976 |
| Alcon | 31 | $29,971 |
| AbbVie(2 entities) | 39 | $25,229 |
| Carl Zeiss Meditec, Inc. | 25 | $22,296 |
| Dutch Ophthalmic Research Center (international) B.v. | 2 | $20,008 |
| Carl Zeiss Meditec USA, Inc. | 14 | $13,253 |
| Genentech USA, Inc. | 27 | $12,077 |
| Eyepoint US, Inc. | 18 | $9,879 |
| Beaver-visitec International, Inc. | 6 | $4,887 |
| Genentech, Inc. | 2 | $2,447 |
| Bausch & Lomb Americas Inc. | 8 | $2,077 |
| Oculus Surgical Inc. | 5 | $1,240 |
| Ocular Therapeutix, Inc. | 3 | $432 |
| Regeneron | 3 | $266 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $210 |
| Notal Vision, Inc. | 1 | $120 |
| Pfizer | 1 | $115 |
| Sun Pharmaceutical Industries Inc. | 1 | $105 |
| Harrow Eye, LLC | 2 | $62 |
| Halozyme Inc | 3 | $54 |
| Biogen | 1 | $28 |
| Baudax Bio Inc. | 1 | $23 |
| Coherus Oncology, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Syfovre$104,614
- Iluvien$95,001
- Izervay$88,554
- EYLEA HD$71,842
- YUTIQ$46,351
- EVA Ophthalmic Surgical System$43,614
- BEOVU$41,594
- PURIFIED CORTROPHIN GEL$41,318
- EVA, combined machine$33,080
- CIRRUS HD-OCT$23,169
- NGENUITY$11,311
- Luxor$11,200
- Alcon Greishaber Finesse$11,200
- OZURDEX$10,925
- TISSUEBLUE$10,818
- Retina Workplace$10,200
- CLARUS$9,722
- CLARUS 500$7,800
- EYLEA$7,305
- SUSVIMO$6,912
How this compares
$797,682 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 67 | $3,178 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 55 | $690 |
| Atropine Sulfate | 17 | $593 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 24 | $398 |
| Latanoprost | 31 | $361 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Palm Beach Gardens
- Mark MilnerPalm Beach Gardens$1.2M
- Larissa CamejoPalm Beach Gardens$244K
- David GoldmanPalm Beach Gardens$239K
- Clifford SalingerPalm Beach Gardens$163K
- Cathleen McCabeBradenton$2M
- Daniel KiernanSarasota$1.7M
- David EichenbaumSt Petersburg$1.7M
- Neel DesaiLargo$1M
- Courtney BoveeTampa$796K
- Harold BrooksTallahassee$683K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.